CervoMed Inc. Impairment of Intangible Assets, Finite-lived
CervoMed Inc. (CRVO) reported Impairment of Intangible Assets, Finite-lived of $3.64 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2016-03-25
- CervoMed Inc. impairment of intangible assets, finite-lived for the quarter ending 2012-12-31 was $153.00K.
- CervoMed Inc. impairment of intangible assets, finite-lived for the quarter ending 2012-09-30 was $197.50K.
- CervoMed Inc. impairment of intangible assets, finite-lived for fiscal 2014 was $3.64M.
- CervoMed Inc. impairment of intangible assets, finite-lived for fiscal 2012 was $350.50K, a 81.15% decline from fiscal 2011.
- CervoMed Inc. impairment of intangible assets, finite-lived for fiscal 2011 was $1.86M.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2014-12-31 | $3.64M 10-K · filed 2016-03-25 | |||
| 2012-12-31 | $153.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $350.50K derived: sum of 2 quarters · filed 2013-04-24 | $350.50K 10-K/A · filed 2013-04-24 | |
| 2012-09-30 | $197.50K 10-Q · filed 2012-11-19 | $197.50K 10-Q · filed 2012-11-19 | ||
| 2011-12-31 | $1.86M 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |